• Explore /
  • Poster
  • / Randomized phase III clinical trial of neoadjuvant intravesical mitomycin C (MMC) treatment in patients with primary treatment-naïve non-muscle invasive bladder cancer (NMIBC).

Randomized phase III clinical trial of neoadjuvant intravesical mitomycin C (MMC) treatment in patients with primary treatment-naïve non-muscle invasive bladder cancer (NMIBC).

Abstract Video & Slides Poster

Authors

null

Massimo Lazzeri

IRCCS Humanitas Research Hospital, Rozzano, Italy

Massimo Lazzeri , Maria Rescigno , Giorgio Ferruccio Guazzoni , Paolo Casale , NicolòMaria Buffi , Giovanni Lughezzani , Stefano Mancon , Vittorio Fasulo , Alberto Saita , Rodolfo Hurle

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

EudraCT 2021-003751-42_studio ICH-013 (MMC)

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr TPS578)

DOI

10.1200/JCO.2023.41.6_suppl.TPS578

Abstract #

TPS578

Poster Bd #

P1

Abstract Disclosures

Similar Posters

First Author: Alberto Saita

First Author: Neal D. Shore

First Author: Shilpa Gupta

First Author: Robert S. Svatek